{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:34:11Z","timestamp":1791200051304,"version":"4.2.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.jaci.2004.07.047","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T11:54:11Z","timestamp":1100001251000},"page":"1209-1215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":338,"title":["Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells"],"prefix":"10.1016","volume":"114","author":[{"given":"Amal","family":"Nassif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Bensussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Boumsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Deniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homayoun","family":"Moslehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.07.047_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2133.1979.tb03571.x","article-title":"Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal","volume":"100","author":"Lyell","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"351","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.07.047_bib3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.07.047_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2004.07.047_bib6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe cutaneous adverse reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.07.047_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1995.tb05016.x","article-title":"CD8+ dermal T-cells from a sulfamethoxazole -induced bullous exanthem proliferate in response to drug-modified liver microsomes","volume":"132","author":"Hertl","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.155.1.462","article-title":"Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfamethoxazole, phenytoin and carbamazepine","volume":"155","author":"Mauri-Hellweg","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.07.047_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.07.047_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific T cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.07.047_bib11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.07.047_bib12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1747.2000.00105.x","article-title":"T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic","volume":"115","author":"Yawalkar","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis, further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/jvi.23.3.503-508.1977","article-title":"Clonal transformation of adult human leukocytes by Epstein-Barr virus","volume":"23","author":"Sugden","year":"1977","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2004.07.047_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1523-1747.ep12455548","article-title":"Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair fillicules","volume":"87","author":"Limat","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.07.047_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/07391102.1995.10508806","article-title":"Conformational modeling of elastin tetrapeptide Boc-Gly-Leu-Gly-Gly-NMe by molecular dynamics simulations with improvements to the thermalization procedure","volume":"12","author":"Villani","year":"1995","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jaci.2004.07.047_bib18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4049\/jimmunol.164.3.1148","article-title":"Cytolytic effector function in human circulating CD8+ T cells correlates with CD56 surface expression","volume":"164","author":"Pittet","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.07.047_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2002.120563","article-title":"Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity","volume":"109","author":"Posadas","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.07.047_bib20","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.07.047_bib21","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/eji.200323630","article-title":"Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes","volume":"33","author":"Azukizawa","year":"2003","journal-title":"Eur J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904021669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904021669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:53:48Z","timestamp":1758776028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904021669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0091674904021669"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.07.047","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}